Video: Early cancer diagnosis seems crucial in children with immune defect

Featured Video Play Icon

(Vienna, 03.12.2020) CD27/CD70 deficiencies can lead to cancer in small children: “If diagnosed at an early stage, the majority of these patients are responsive to the hematopoietic stem cell treatment”, says Co-first author Sevgi Köstel Bal, MD, Phd, St. Anna Children's Cancer Research Institute (CCRI)’s, in a video statement on a new global study: Extended Clinical and Immunological Phenotype and Transplant Outcome in CD27 and CD70 Deficiency.

Published in the Journal Blood, the study gives insights into clinical course and early immunological parameters as well as treatment response in the largest group of children with CD27 or CD70 deficiency to date.

Go to press release: https://www.ccri.at/2020/12/02/cancer-in-children-with-rare-inborn-immune-defect-high-cure-rate-if-treated-early/